CORC

在结果中检索

CORC

浏览/检索结果: 共161条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial 期刊论文
BRITISH JOURNAL OF CANCER, 2022
作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili
收藏  |  浏览/下载：18/0  |  提交时间：2022/12/22
Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements 期刊论文
LIVER CANCER, 2022, 卷号: 11
作者:  Sun, Yongkun;  Zhang, Wen;  Bi, Xinyu;  Yang, Zhengqiang;  Tang, Yu
收藏  |  浏览/下载：30/0  |  提交时间：2022/12/23
Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer The REALITY Randomized Clinical Trial 期刊论文
JAMA ONCOLOGY, 2021
作者:  Lin, Yansong;  Qin, Shukui;  Li, Zhiyong;  Yang, Hui;  Fu, Wei
收藏  |  浏览/下载：55/0  |  提交时间：2022/01/25
Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Jin;  Qin, Shukui;  Wen, Lu;  Wang, Junsheng;  Deng, Wenying
收藏  |  浏览/下载：22/0  |  提交时间：2022/01/10
Efficacy and safety of HLX10, a novel anti-PD-1 antibody, in patients with previously treated unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors: A single-arm, multicenter, phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili
收藏  |  浏览/下载：19/0  |  提交时间：2022/01/10
Clinical effectiveness of apatinib at different doses in patients with advanced gastric cancer as the third-line or further treatment: Results from a post-marketing phase IV study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Jin;  Qin, Shukui;  Wen, Lu;  Wang, Junsheng;  Deng, Wenying
收藏  |  浏览/下载：26/0  |  提交时间：2022/01/10
Safety, Clinical Activity, and Pharmacokinetics of Al flutinib (AST2818) in Patients With Advanced NSCLC With EGFR T790M Mutation 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15, 期号: 6, 页码: 1015-1026
作者:  Shi, Yuankai;  Zhang, Shucai;  Hu, Xingsheng;  Feng, Jifeng;  Ma, Zhiyong
收藏  |  浏览/下载：36/0  |  提交时间：2020/12/24
To Take or Not to Take a Side: That Is the Question Reply 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2019, 卷号: 37, 期号: 18
作者:  Qin, Shukui;  Liu, Tianshu;  Li, Jin
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial 期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载：112/0  |  提交时间：2019/12/05
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial 期刊论文
ONCOLOGIST, 2019, 卷号: 24, 期号: 8
作者:  Zhou, Ai-Ping;  Bai, Yuxian;  Song, Yan;  Luo, Hong;  Ren, Xiu-Bao
收藏  |  浏览/下载：30/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace